Monument Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.17M | Buy |
2,769
+155
| +6% | +$61.8K | 0.24% | 100 |
|
|
2026
Q2 | $947K | Sell |
2,614
-52
| -2% | -$17.8K | 0.19% | 115 |
|
|
2026
Q1 | $938K | Sell |
2,666
-122
| -4% | -$43.5K | 0.24% | 100 |
|
|
2025
Q4 | $913K | Buy |
2,788
+1,412
| +103% | +$448K | 0.23% | 100 |
|
|
2025
Q3 | $388K | Sell |
1,376
-62
| -4% | -$18K | 0.1% | 153 |
|
|
2025
Q2 | $401K | Sell |
1,438
-182
| -11% | -$51.6K | 0.1% | 142 |
|
|
2025
Q1 | $505K | Sell |
1,620
-123
| -7% | -$36.3K | 0.16% | 116 |
|
|
2024
Q4 | $454K | Sell |
1,743
-359
| -17% | -$107K | 0.13% | 123 |
|
|
2024
Q3 | $677K | Buy |
2,102
+43
| +2% | +$14.1K | 0.19% | 93 |
|
|
2024
Q2 | $643K | Sell |
2,059
-101
| -5% | -$29.7K | 0.19% | 92 |
|
|
2024
Q1 | $614K | Sell |
2,160
-76
| -3% | -$22.2K | 0.18% | 102 |
|
|
2023
Q4 | $644K | Buy |
2,236
+66
| +3% | +$18K | 0.21% | 100 |
|
|
2023
Q3 | $583K | Buy |
2,170
+687
| +46% | +$171K | 0.2% | 94 |
|
|
2023
Q2 | $329K | Sell |
1,483
-844
| -36% | -$196K | 0.11% | 128 |
|
|
2023
Q1 | $563K | Buy |
2,327
+83
| +4% | +$20.4K | 0.19% | 90 |
|
|
2022
Q4 | $589K | Buy |
2,244
+880
| +65% | +$236K | 0.2% | 91 |
|
|
2022
Q3 | $308K | Buy |
1,364
+128
| +10% | +$31K | 0.12% | 122 |
|
|
2022
Q2 | $301K | Buy |
+1,236
| New | +$303K | 0.11% | 118 |
|
|
2021
Q4 | – | Sell |
-2,362
| Closed | -$502K | – | 143 |
|
|
2021
Q3 | $502K | Buy |
2,362
+86
| +4% | +$19.8K | 0.17% | 105 |
|
|
2021
Q2 | $555K | Buy |
+2,276
| New | +$560K | 0.19% | 94 |
|
|
2021
Q1 | – | Sell |
-9,548
| Closed | -$2.2M | – | 108 |
|
|
2020
Q4 | $2.2M | Buy |
9,548
+743
| +8% | +$171K | 1.01% | 53 |
|
|
2020
Q3 | $2.24M | Buy |
8,805
+264
| +3% | +$65.4K | 1.18% | 43 |
|
|
2020
Q2 | $2.01M | Sell |
8,541
-92
| -1% | -$21K | 1.18% | 40 |
|
|
2020
Q1 | $1.75M | Buy |
8,633
+341
| +4% | +$74.5K | 1.26% | 41 |
|
|
2019
Q4 | $2M | Buy |
8,292
+66
| +0.8% | +$14.5K | 1.02% | 50 |
|
|
2019
Q3 | $1.59M | Sell |
8,226
-204
| -2% | -$39.2K | 0.86% | 54 |
|
|
2019
Q2 | $1.57M | Buy |
+8,430
| New | +$1.51M | 0.85% | 54 |
|
|
2018
Q4 | – | Sell |
-13
| Closed | -$3K | – | 100 |
|
|
2018
Q3 | $3K | Buy |
+13
| New | +$2.56K | ﹤0.01% | 208 |
|
Other funds holding AMGN
Monument Capital Management's AMGN Position: Q3 2026 in Review
Monument Capital Management increased its Amgen (AMGN) stake by 5.9% in Q3 2026, buying an estimated $61.8K and bringing the position to 2,769 shares worth $1.17M. The position accounts for 0.24% of the portfolio, ranked #100.
Monument Capital Management first reported a position in AMGN in Q3 2018 and has held it in 28 quarters since. The position peaked at $2.24M in Q3 2020. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Monument Capital Management held 2,769 shares of Amgen worth $1.17M as of Q3 2026.
- Monument Capital Management bought 155 Amgen shares in Q3 2026, an estimated $61.8K.
- Amgen made up 0.24% of Monument Capital Management's portfolio in Q3 2026, its #100 holding.
- Monument Capital Management first reported a position in Amgen in Q3 2018 and has held it in 28 quarters since.
- Monument Capital Management's Amgen position peaked at $2.24M in Q3 2020.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Monument Capital Management's 13F filing for Q3 2026, filed 9 Oct 2026.